Expand Access for the Rewalk Personal Exoskeleton
Published: 10 Mar 2026
Author: Precedence Research
Lifeward is a global leader that helps to transform the lives of people with physical limitations or disabilities. Shriley Ryan AbilityLab, a global leader in physical medicine and rehabilitation, has partnered to launch a dedicated clinic in the second quarter of 2026, aiming to accelerate accessibility to the Rewalk Personal Exoskeleton. These specialised clinics provide individuals living with spinal cord injury the opportunity to evaluate and promote functional ambulation and greater independence.
About Shirley Ryan AbilityLab
It is the global leader in physical medicine and rehabilitation for adults and children with the most complex conditions, from traumatic brain and spinal cord injury to stroke and cancer-related impairment. It was designated the no. 1 rehabilitation hospital in America by U.S. News & World Report in 1991.
With the development and innovation of new technology, researchers have found a new approach in translational research for rehabilitation hospitals. This latest model offers patients access to the latest research and the best opportunity for recovery.
According to Toward Healthcare, the U.S. exoskeleton market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 284.55 million in 2026 to approximately USD 864.37 million by 2035, representing a compound annual growth rate (CAGR) of 13.14% from 2026 to 2035. This growth may facilitate a more streamlined pathway from evaluation to real-world use of ReWalk for people living with spinal cord injury (SCI).
AboutLifeward
It is to relentlessly drive to change the lives of individuals with physical limitations or disabilities. It was founded in 2001 and has operations in the United States, Israel, and Germany. They are committed to delivering ground-breaking solutions that empower individuals to choose what they want to do. Features innovative products, including the ReWalk Exoskeleton, the AlterG Anti-Gravity systems, and the ReStore Exo-Suit.
Mark Grant, CEO at Lifeward, said: “This work with Shirley Ryan AbilityLab, a prestigious nationally recognised rehabilitation research hospital, is a first for Lifeward.”
Forward-looking statement
It is based on management's current expectations, which are subject to uncertainty, risks, and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. Uncertainties are associated with future clinical trials and the clinical development process, the product development process, and the FDA regulatory submission review and approval process.
A recent report by Towards Healthcare highlights that the U.S. exoskeleton market supports technologies enabling individuals with spinal cord injury to stand, walk, and navigate environments with stairs and curbs. The report also indicates that powered exoskeleton technology is associated with improved ambulation, health outcomes, and quality of life for these individuals.